ECCT for Advanced Lung Cancer: ECCT shows promise in treating lung adenocarcinomas, particularly in advanced stages where surgery isn’t an option. Tumors with EGFR-positive mutations respond better, though the exact mechanism remains unclear. Larger tumors may shrink, potentially leaving fibrosis linked to longer treatment and inflammation.

 

ECCT for Brain Tumors: For inoperable brain tumors in regions like the diencephalon and brainstem, ECCT offers a non-invasive option. Its effectiveness depends on the tumor's type and location. Softer, highly polarized tumors respond well, while harder ones depend on their connection to excretion channels.

 

ECCT for Untreatable Cancers: ECCT is suitable for malignant cancers with small metastatic lesions resistant to conventional treatments. These lesions respond well to non-contact electric fields, allowing effective targeting and safe excretion of cancer cells, offering a non-invasive option to manage progression.

 

Seizure-Inducing Euphoria (ECT): Electroconvulsive Therapy (ECT), performed under general anesthesia, uses small electric currents to induce brief seizures, altering brain chemistry. This can rapidly improve symptoms in certain mental health conditions, especially when other treatments fail.